Bayer Helps J&J Expand Cardiology Franchise
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 66 (Table of Contents)
Published: 5 Dec-2005
DOI: 10.3833/pdr.v2005.i66.590 ISSN: 1756-7874
Section: General
Fulltext:
Abstract
Bayer HealthCare and Ortho-McNeil Pharmaceutical entered into license agreement to jointly develop and market Factor Xa inhibitor BAY 59-7939 which is in phase 2 clinical trials for preventing and treating thrombosis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS